Phoenix Life Sciences International Limited (OTCPK:PLSI) announced that it will receive $40,000,000 in a round of funding on April 30, 2019. The company will issue 3,200,000 common shares at a price of $12.50 per share in the transaction. The minimum investment accepted from any outside investor is $50,000. The minimum subscription will be 2,000 shares foe gross proceeds of $25,000. The transaction will include participation from accredited investors, including qualified family offices and institutional investors.